Načítá se...
Could the properties of IL-27 make it an ideal adjuvant for anticancer immunotherapy?
We have recently been the first to demonstrate that interleukin (IL)-27 protects against the emergence and progression of autochthonous tumors. Accumulating evidence suggests that IL-27 might be uniquely well positioned to amplify beneficial T(H)1 anticancer immune responses while suppressing the un...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Landes Bioscience
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3782520/ https://ncbi.nlm.nih.gov/pubmed/24083081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.25409 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|